{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:13Z","timestamp":1786993693176,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":203,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.lrr.2025.100531","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T23:30:52Z","timestamp":1753313452000},"page":"100531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Treatment outcomes and survival analysis of pediatric mature B-Cell non-Hodgkin lymphoma: A retrospective study comparing LMB96 and R-CHOP regimens"],"prefix":"10.1016","volume":"24","author":[{"given":"Hamid D. Habeeb","family":"Rjeib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Al-Jumaily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inas Muayad Mohammed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Faraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Fawzi","family":"Al-Qanbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheyaa Aldeen","family":"Al-Khateeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaima","family":"Jabbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lrr.2025.100531_bib0001","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2019.043","article-title":"Malnutrition, sepsis, and tumor lysis syndrome are associated with increased rate of acute mortality in mature B cell non-hodgkin lymphoma in a pediatric population-study from tertiary care hospital in Pakistan","volume":"11","author":"Mansoor","year":"2019","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.lrr.2025.100531_bib0002","doi-asserted-by":"crossref","DOI":"10.5045\/br.2021.2021164","article-title":"Clinical characteristics and treatment outcomes of children and adolescents with aggressive mature B-cell lymphoma: a single-center analysis","volume":"57","author":"Jeon","year":"2022","journal-title":"Blood Res."},{"issue":"6","key":"10.1016\/j.lrr.2025.100531_bib0003","doi-asserted-by":"crossref","DOI":"10.1097\/MPH.0000000000002699","article-title":"Prognostic factors and treatment outcome of relapsing and refractory pediatric mature B-cell non-hodgkin lymphoma, children\u2019s Cancer Hospital Egypt experience","volume":"45","author":"Semary","year":"2023","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"04","key":"10.1016\/j.lrr.2025.100531_bib0004","doi-asserted-by":"crossref","DOI":"10.4236\/jct.2015.64033","article-title":"Pediatric non-hodgkin lymphoma: a retrospective 7-year experience in children & adolescents with non-hodgkin lymphoma treated in King Fahad Medical City (KFMC)","volume":"06","author":"Mobark","year":"2015","journal-title":"J Cancer Ther."},{"issue":"2","key":"10.1016\/j.lrr.2025.100531_bib0005","doi-asserted-by":"crossref","DOI":"10.14319\/ijcto.32.15","article-title":"Pediatric mature B-cell non hodgkin lymphoma treatment with LMB-96 protocol. The Children Cancer Hospital Egypt experience","volume":"3","author":"Abdel Rahman","year":"2015","journal-title":"Int. J. Cancer Ther. Oncol."},{"key":"10.1016\/j.lrr.2025.100531_bib0006","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.55949","article-title":"Intestinal intussusception complicating an undiagnosed burkitt lymphoma in a pediatric Arab patient","author":"Alghenaim","year":"2024","journal-title":"Cureus"},{"issue":"16","key":"10.1016\/j.lrr.2025.100531_bib0007","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-05-349662","article-title":"Molecular distinctions between pediatric and adult mature B-cell non-hodgkin lymphomas identified through genomic profiling","volume":"119","author":"Deffenbacher","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2025.100531_bib0008","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.020","article-title":"Outcome and toxicity patterns in children and adolescents with non-Hodgkin lymphoma: a single institution experience","volume":"10","author":"Angelini","year":"2018","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.lrr.2025.100531_bib0009","doi-asserted-by":"crossref","unstructured":"S.H. Swerdlow et al., \u201cThe 2016 revision of the World Health Organization classification of lymphoid neoplasms,\u201d 2016. doi: 10.1182\/blood-2016-01-643569.","DOI":"10.1182\/blood-2016-01-643569"},{"issue":"3","key":"10.1016\/j.lrr.2025.100531_bib0010","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin\u2019s lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy","year":"1980","journal-title":"Semin. Oncol."},{"issue":"11","key":"10.1016\/j.lrr.2025.100531_bib0011","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.lrr.2025.100531_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/bjc.1998.379","article-title":"Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin\u2019s lymphoma (B-NHL)- results of the UKCCSG 9003 protocol","volume":"77","author":"Atra","year":"1998","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.lrr.2025.100531_bib0013","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lrr.2025.100531_bib0014","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus Rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.lrr.2025.100531_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.17979","article-title":"Childhood aggressive B-cell non-hodgkin lymphoma in low\u2013middle-income countries","volume":"196","author":"Moleti","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.lrr.2025.100531_bib0016","doi-asserted-by":"crossref","unstructured":"T.G. Gross and A. Biondi, \u201cPaediatric non-Hodgkin lymphoma in low and middle income countries,\u201d 2016. doi: 10.1111\/bjh.14030.","DOI":"10.1111\/bjh.14030"},{"issue":"5","key":"10.1016\/j.lrr.2025.100531_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27621","article-title":"Outcome of pediatric non-Hodgkin lymphoma in Central America: a report of the Association of Pediatric Hematology Oncology of Central America (AHOPCA)","volume":"66","author":"Pe\u00f1a-Hernandez","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"issue":"Supplement 1","key":"10.1016\/j.lrr.2025.100531_bib0018","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2021-146604","article-title":"Sex differences in lymphoma incidence and excess mortality by subtype: a comprehensive national study","volume":"138","author":"Radkiewicz","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2025.100531_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26744","article-title":"Sex differences in lymphoma incidence and mortality by subtype: a population-based study","volume":"98","author":"Radkiewicz","year":"2023","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.lrr.2025.100531_bib0020","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2013.101741","article-title":"Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma","volume":"99","author":"Wilson","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.lrr.2025.100531_bib0021","series-title":"Haematologica","article-title":"Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study","author":"Zayac","year":"2021"},{"issue":"10_Supplement","key":"10.1016\/j.lrr.2025.100531_bib0022","doi-asserted-by":"crossref","DOI":"10.1158\/1940-6207.PREV-11-B93","article-title":"Abstract B93: clinical characteristics, treatment, and outcome of childhood Burkitt\u2019s lymphoma in the Uganda Cancer Institute","volume":"4","author":"Weiderpass","year":"2011","journal-title":"Cancer Prev. Res."},{"issue":"12","key":"10.1016\/j.lrr.2025.100531_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.trstmh.2011.08.008","article-title":"Clinical characteristics, treatment and outcome of childhood Burkitt\u2019s lymphoma at the Uganda Cancer Institute","volume":"105","author":"Orem","year":"2011","journal-title":"Trans. R Soc. Trop Med. Hyg."},{"issue":"24","key":"10.1016\/j.lrr.2025.100531_bib0024","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2012-12-475558","article-title":"Trends in survival of patients with Burkitt lymphoma\/leukemia in the USA: an analysis of 3691 cases","volume":"121","author":"Costa","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2025.100531_bib0025","doi-asserted-by":"crossref","unstructured":"F. Frontzek, I. Karsten, N. Schmitz, and G. Lenz, \u201cCurrent options and future perspectives in the treatment of patients with relapsed\/refractory diffuse large B-cell lymphoma,\u201d 2022. doi: 10.1177\/20406207221103321.","DOI":"10.1177\/20406207221103321"},{"issue":"2","key":"10.1016\/j.lrr.2025.100531_bib0026","doi-asserted-by":"crossref","DOI":"10.5045\/br.2014.49.2.107","article-title":"R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma","volume":"49","author":"Lee","year":"2014","journal-title":"Blood Res."},{"key":"10.1016\/j.lrr.2025.100531_bib0027","doi-asserted-by":"crossref","unstructured":"A.C. Xavier, R. Suzuki, and A. Attarbaschi, \u201cDiagnosis and management of rare paediatric Non-Hodgkin lymphoma,\u201d 2023. doi: 10.1016\/j.beha.2023.101440.","DOI":"10.1016\/j.beha.2023.101440"},{"key":"10.1016\/j.lrr.2025.100531_bib0028","doi-asserted-by":"crossref","unstructured":"S. Goldman and M.S. Cairo, \u201cDiagnosis and management of mature B-cell lymphomas in children, adolescents, and young adults,\u201d 2023. doi: 10.1016\/j.beha.2023.101463.","DOI":"10.1016\/j.beha.2023.101463"},{"issue":"21","key":"10.1016\/j.lrr.2025.100531_bib0029","article-title":"Safety of Rituximab combined with intensive chemotherapy in the treatment of childhood aggressive mature B-cell lymphoma\/leukemia","volume":"36","author":"Xu","year":"2021","journal-title":"Chin. J. Appl. Clin. Pediatr."},{"key":"10.1016\/j.lrr.2025.100531_bib0030","doi-asserted-by":"crossref","unstructured":"M.S. Cairo, \u201cRituximab in the treatment of childhood mature B-cell lymphoma: \u2018where do we go from here,\u2019\u201d 2019. doi: 10.1111\/bjh.15940.","DOI":"10.1111\/bjh.15940"},{"issue":"23","key":"10.1016\/j.lrr.2025.100531_bib0031","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1915315","article-title":"Rituximab for high-risk, mature B-cell non-Hodgkin\u2019s lymphoma in children","volume":"382","author":"Minard-Colin","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.lrr.2025.100531_bib0032","article-title":"Pediatric aggressive mature B-Cell Lymphomas, version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Davies","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T12:47:48Z","timestamp":1764852468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048925000330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":32,"alternative-id":["S2213048925000330"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100531","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment outcomes and survival analysis of pediatric mature B-Cell non-Hodgkin lymphoma: A retrospective study comparing LMB96 and R-CHOP regimens","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100531"}}